These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33026158)

  • 1. Variation in immunosuppression practices among pediatric liver transplant centers-Society of Pediatric Liver Transplantation survey results.
    Slowik V; Lerret SM; Lobritto SJ; Voulgarelis S; Vitola BE
    Pediatr Transplant; 2021 Mar; 25(2):e13873. PubMed ID: 33026158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice patterns are relatively uniform between pediatric heart transplant centers: A survey-based assessment.
    Castleberry C; Ziniel S; Almond C; Auerbach S; Hollander SA; Lal AK; Fenton M; Pahl E; Rossano JW; Everitt MD; Daly KP
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28670871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice variation in the immediate postoperative care of pediatric liver transplant patients: Framework for a national consensus.
    Maue DK; Mangus RS; Lutfi R; Hobson MJ; Rao GS; Nitu ME; Abu-Sultaneh S
    Pediatr Transplant; 2021 Aug; 25(5):e13976. PubMed ID: 33502816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression Practices in Liver Transplantation: A Survey of North American Centers.
    Hussaini T; Turgeon RD; Partovi N; Erb SR; Scudamore CH; Yoshida EM
    Exp Clin Transplant; 2018 Oct; 16(5):550-553. PubMed ID: 28847263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early surveillance biopsy utilization and management of pediatric renal allograft acute T cell-mediated rejection in Canadian centers: Observations from the PROBE multicenter cohort study.
    Hoffmann AJ; Gibson IW; Ho J; Nickerson P; Rush D; Sharma A; Wishart D; Blydt-Hansen TD
    Pediatr Transplant; 2021 Mar; 25(2):e13870. PubMed ID: 33026135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction Immunosuppression and Renal Outcomes in Adult Heart Transplantation.
    Diaz-Castrillon CE; Huckaby LV; Hickey G; Sultan I; Kilic A
    J Surg Res; 2021 Mar; 259():14-23. PubMed ID: 33278793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression in the pediatric transplant recipient.
    Blondet NM; Healey PJ; Hsu E
    Semin Pediatr Surg; 2017 Aug; 26(4):193-198. PubMed ID: 28964473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of early immunosuppression on pediatric liver transplant outcomes within 1 year.
    Raghu VK; Zhang X; Squires JE; Eisenberg E; Feldman AG; Halma J; Peters AL; Gonzalez-Peralta RP; Ng VL; Horslen SP; Lobritto SJ; Bucuvalas J; Mazariegos GV; Perito ER
    J Pediatr Gastroenterol Nutr; 2024 Feb; 78(2):328-338. PubMed ID: 38374561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.
    Singh TP; Faber C; Blume ED; Worley S; Almond CS; Smoot LB; Dillis S; Nasman C; Boyle GJ
    J Heart Lung Transplant; 2010 May; 29(5):517-22. PubMed ID: 20061164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.
    Aoun B; Decramer S; Vitkevic R; Wannous H; Bandin F; Azema C; Callard P; Brocheriou I; Ulinski T
    Pediatr Nephrol; 2013 Mar; 28(3):493-8. PubMed ID: 23111894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter survey on post-transplant lymphoproliferative disorders in pediatric heart transplant recipients: A case for development of consensus guidelines for screening, surveillance, and treatment?
    Weisert M; Harake D; Hede S; Russell M; Alejos J; Menteer J
    Pediatr Transplant; 2020 Aug; 24(5):e13730. PubMed ID: 32416037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative anticoagulation practices for pediatric liver transplantation.
    Voulgarelis S; Vitola B; Lerret SM; Hong JC; Scott JP
    Pediatr Transplant; 2018 Jun; 22(4):e13193. PubMed ID: 29663585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.
    Solomon S; Colovai A; Del Rio M; Hayde N
    Pediatr Nephrol; 2020 Feb; 35(2):261-270. PubMed ID: 31732803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid-avoidance protocols in pediatric renal transplantation.
    Puliyanda DP; Pizzo H; Rodig N; Somers MJG
    Pediatr Transplant; 2020 May; 24(3):e13685. PubMed ID: 32112514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
    Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight-year follow-up in pediatric living donor kidney recipients receiving alemtuzumab induction.
    Kaabak MM; Babenko NN; Shapiro R; Maschan AA; Zokoev AK; Schekaturov SV; Vyunkova JN; Dymova OV
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28600850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of rabbit anti-thymocyte globulin vs basiliximab induction in pediatric liver transplant recipients.
    Newland DM; Royston MJ; McDonald DR; Nemeth TL; Wallace-Boughter K; Carlin K; Horslen S
    Pediatr Transplant; 2019 Dec; 23(8):e13573. PubMed ID: 31512802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.